Charles Tindell

2.5k total citations
10 papers, 748 citations indexed

About

Charles Tindell is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Charles Tindell has authored 10 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Charles Tindell's work include Epigenetics and DNA Methylation (3 papers), Cancer-related gene regulation (3 papers) and Immune Response and Inflammation (2 papers). Charles Tindell is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Cancer-related gene regulation (3 papers) and Immune Response and Inflammation (2 papers). Charles Tindell collaborates with scholars based in United States and Canada. Charles Tindell's co-authors include André E. Nel, Ali Khoshnan, D. Bae, Isett Laux, Brydon L. Bennett, David B. Agus, Anjali Jain, John A. Curran, Marie Classon and Gulfem D. Guler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Charles Tindell

10 papers receiving 732 citations

Peers

Charles Tindell

IMMUN

ONCOL

PRM

Isett Laux United States

Zhou-Luo Ou China

Kurt Kofler Austria

Johanna Wagner Germany

Amal Qattan Saudi Arabia

Suzanne Egyházi Brage Sweden

Maria Diez‐Rodriguez United Kingdom

Gianmaria Liccardi United Kingdom

Rainer Tuominen Sweden

Xuening Ji China

Isett Laux United States

Charles Tindell

331 ×0.8

211 ×0.8

IMMUN

225 ×1.1

ONCOL

127 ×0.7

137 ×1.8

PRM

Citations per year, relative to Charles Tindell Charles Tindell (= 1×) peers Isett Laux

Countries citing papers authored by Charles Tindell

Since Specialization

Citations

This map shows the geographic impact of Charles Tindell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Tindell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Tindell more than expected).

Fields of papers citing papers by Charles Tindell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Tindell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Tindell. The network helps show where Charles Tindell may publish in the future.

Co-authorship network of co-authors of Charles Tindell

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Tindell. A scholar is included among the top collaborators of Charles Tindell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Tindell. Charles Tindell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Pham, Victoria C., Robert Pitti, Charles Tindell, et al.. (2020). Proteomic Analyses Identify a Novel Role for EZH2 in the Initiation of Cancer Cell Drug Tolerance. Journal of Proteome Research. 19(4). 1533–1547. 16 indexed citations

Egan, Brian, Chih-Chi Yuan, Madeleine Craske, et al.. (2016). An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition. PLoS ONE. 11(11). e0166438–e0166438. 85 indexed citations

Maile, Tobias M, Anita Izrael-Tomasevic, Tommy K. Cheung, et al.. (2015). Mass Spectrometric Quantification of Histone Post-translational Modifications by a Hybrid Chemical Labeling Method. Molecular & Cellular Proteomics. 14(4). 1148–1158. 77 indexed citations

Jain, Anjali, Elicia Penuel, Sheldon Mink, et al.. (2010). HER Kinase Axis Receptor Dimer Partner Switching Occurs in Response to EGFR Tyrosine Kinase Inhibition despite Failure to Block Cellular Proliferation. Cancer Research. 70(5). 1989–1999. 56 indexed citations

Gross, Mitchell E., Isett Laux, Jonathan E. Katz, et al.. (2007). β-2-Microglobulin Is an Androgen-Regulated Secreted Protein Elevated in Serum of Patients with Advanced Prostate Cancer. Clinical Cancer Research. 13(7). 1979–1986. 51 indexed citations

Jain, Anjali, Charles Tindell, Isett Laux, et al.. (2005). Epithelial membrane protein-1 is a biomarker of gefitinib resistance. Proceedings of the National Academy of Sciences. 102(33). 11858–11863. 74 indexed citations

Laux, Isett, Anjali Jain, Charles Tindell, & David B. Agus. (2004). Epidermal growth factor receptor dimerization status determines response to HER-kinase targeted therapies in keratinocytes. Journal of Clinical Oncology. 22(14_suppl). 3062–3062. 1 indexed citations

Khoshnan, Ali, D. Bae, Charles Tindell, & André E. Nel. (2000). The Physical Association of Protein Kinase Cθ with a Lipid Raft-Associated Inhibitor of κB Factor Kinase (IKK) Complex Plays a Role in the Activation of the NF-κB Cascade by TCR and CD28. The Journal of Immunology. 165(12). 6933–6940. 121 indexed citations

Khoshnan, Ali, Charles Tindell, Isett Laux, et al.. (2000). The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes. The Journal of Immunology. 165(4). 1743–1754. 194 indexed citations

10.

Laux, Isett, Ali Khoshnan, Charles Tindell, et al.. (2000). Response Differences between Human CD4+ and CD8+ T-Cells during CD28 Costimulation: Implications for Immune Cell-Based Therapies and Studies Related to the Expansion of Double-Positive T-Cells during Aging. Clinical Immunology. 96(3). 187–197. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact